| ABEONA THERAPEUTICS |
| USA |
| Gesundheit |
| US00289Y2063 / A3DMHM |
| PCJ (Frankfurt) / ABEO (NASDAQ) |
| FRA:PCJ, ETR:PCJ, PCJ:GR, NASDAQ:ABEO |
| - |
| https://www.abeonatherape.. |
|
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and delivering cell and gene therapies for serious rare diseases. Its current portfolio centers on ZEVASKYN, an autologous cell-based gene therapy for rece..
>Volltext.. |
| 216.62 Mio. EUR |
| 104.58 Mio. EUR |
| 22.91 Mio. EUR |
| -71.75 Mio. EUR |
| -56.45 Mio. EUR |
| -1.01 EUR |
| 17.84 Mio. EUR |
| 50.47 Mio. EUR |
| -68.62 Mio. EUR |
| 5.92 |
| 6480.72% |
| -213.32% |
| - |
| - |
| - |
| - |
| ABEONA THERAPEUTICS, ABEONA THERAPEUTIC |
| 09.11.26 |
|
||||
|
||||
|
||||
|
||||
|